• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

NLRC5 的核输入和输出平衡调节 MHC I 类分子的转激活。

The balance between nuclear import and export of NLRC5 regulates MHC class I transactivation.

机构信息

Department of Immunology, Hokkaido University Graduate School of Medicine, Sapporo, Japan.

Department of Immunology, Hokkaido University Graduate School of Medicine, Sapporo, Japan; Institute for Vaccine Research and Development (HU-IVReD), Hokkaido University, Sapporo, Japan.

出版信息

J Biol Chem. 2024 May;300(5):107205. doi: 10.1016/j.jbc.2024.107205. Epub 2024 Mar 20.

DOI:10.1016/j.jbc.2024.107205
PMID:38519032
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11044055/
Abstract

Major histocompatibility complex (MHC) class I molecules play an essential role in regulating the adaptive immune system by presenting antigens to CD8 T cells. CITA (MHC class I transactivator), also known as NLRC5 (NLR family, CARD domain-containing 5), regulates the expression of MHC class I and essential components involved in the MHC class I antigen presentation pathway. While the critical role of the nuclear distribution of NLRC5 in its transactivation activity has been known, the regulatory mechanism to determine the nuclear localization of NLRC5 remains poorly understood. In this study, a comprehensive analysis of all domains in NLRC5 revealed that the regulatory mechanisms for nuclear import and export of NLRC5 coexist and counterbalance each other. Moreover, GCN5 (general control non-repressed 5 protein), a member of HATs (histone acetyltransferases), was found to be a key player to retain NLRC5 in the nucleus, thereby contributing to the expression of MHC class I. Therefore, the balance between import and export of NLRC5 has emerged as an additional regulatory mechanism for MHC class I transactivation, which would be a potential therapeutic target for the treatment of cancer and virus-infected diseases.

摘要

主要组织相容性复合体(MHC)I 类分子通过将抗原呈递给 CD8 T 细胞,在调节适应性免疫系统方面发挥着重要作用。CITA(MHC I 类转激活物),也称为 NLRC5(NLR 家族,CARD 结构域包含 5),调节 MHC I 类的表达和 MHC I 类抗原呈递途径中涉及的必需成分。尽管 NLRC5 的核分布在其转录激活活性中的关键作用已经众所周知,但决定 NLRC5 核定位的调节机制仍知之甚少。在这项研究中,对 NLRC5 所有结构域的全面分析表明,NLRC5 的核输入和输出的调节机制并存且相互制衡。此外,发现 GCN5(一般控制非抑制 5 蛋白),一种 HATs(组蛋白乙酰转移酶)的成员,是将 NLRC5 保留在核内的关键因素,从而有助于 MHC I 类的表达。因此,NLRC5 的输入和输出之间的平衡已成为 MHC I 类转录激活的另一种调节机制,这可能成为治疗癌症和病毒感染性疾病的潜在治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3cc/11044055/d84bad40fbab/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3cc/11044055/ad873e2a5037/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3cc/11044055/806af2ca9fc5/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3cc/11044055/4f751fc033b4/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3cc/11044055/d5d4f1a49630/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3cc/11044055/778320c88b75/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3cc/11044055/d84bad40fbab/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3cc/11044055/ad873e2a5037/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3cc/11044055/806af2ca9fc5/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3cc/11044055/4f751fc033b4/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3cc/11044055/d5d4f1a49630/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3cc/11044055/778320c88b75/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3cc/11044055/d84bad40fbab/gr6.jpg

相似文献

1
The balance between nuclear import and export of NLRC5 regulates MHC class I transactivation.NLRC5 的核输入和输出平衡调节 MHC I 类分子的转激活。
J Biol Chem. 2024 May;300(5):107205. doi: 10.1016/j.jbc.2024.107205. Epub 2024 Mar 20.
2
Class I transactivator, NLRC5: a central player in the MHC class I pathway and cancer immune surveillance.I 类转录激活物 NLRC5:MHC I 类途径和癌症免疫监视的核心参与者。
Immunogenetics. 2019 Mar;71(3):273-282. doi: 10.1007/s00251-019-01106-z. Epub 2019 Jan 31.
3
The nucleotide-binding domain of NLRC5 is critical for nuclear import and transactivation activity.NLRC5 的核苷酸结合域对于核输入和反式激活活性至关重要。
Biochem Biophys Res Commun. 2012 Feb 24;418(4):786-91. doi: 10.1016/j.bbrc.2012.01.104. Epub 2012 Jan 28.
4
NLRC5/MHC class I transactivator is a target for immune evasion in cancer.NLRC5/主要组织相容性复合体I类反式激活因子是癌症免疫逃逸的一个靶点。
Proc Natl Acad Sci U S A. 2016 May 24;113(21):5999-6004. doi: 10.1073/pnas.1602069113. Epub 2016 May 9.
5
NLRC5: a newly discovered MHC class I transactivator (CITA).NLRC5:一种新发现的 MHC Ⅰ类转录激活物(CITA)。
Microbes Infect. 2012 Jun;14(6):477-84. doi: 10.1016/j.micinf.2011.12.007. Epub 2011 Dec 22.
6
NLR family member NLRC5 is a transcriptional regulator of MHC class I genes.NLR 家族成员 NLRC5 是 MHC Ⅰ类基因的转录调节因子。
Proc Natl Acad Sci U S A. 2010 Aug 3;107(31):13794-9. doi: 10.1073/pnas.1008684107. Epub 2010 Jul 16.
7
The N-terminal domain of NLRC5 confers transcriptional activity for MHC class I and II gene expression.NLRC5的N端结构域赋予了MHC I类和II类基因表达的转录活性。
J Immunol. 2014 Sep 15;193(6):3090-100. doi: 10.4049/jimmunol.1401065. Epub 2014 Aug 15.
8
NLRC5 cooperates with the RFX transcription factor complex to induce MHC class I gene expression.NLRC5 与 RFX 转录因子复合物协同诱导 MHC I 类基因表达。
J Immunol. 2012 May 15;188(10):4951-8. doi: 10.4049/jimmunol.1103160. Epub 2012 Apr 6.
9
Emerging Major Histocompatibility Complex Class I-Related Functions of NLRC5.NLRC5 的新兴主要组织相容性复合体 I 相关功能。
Adv Immunol. 2017;133:89-119. doi: 10.1016/bs.ai.2016.11.003. Epub 2017 Jan 3.
10
CITA/NLRC5: A critical transcriptional regulator of MHC class I gene expression.CITA/NLRC5:MHC I类基因表达的关键转录调节因子。
Biofactors. 2016 Jul 8;42(4):349-57. doi: 10.1002/biof.1285. Epub 2016 Apr 18.

引用本文的文献

1
New insights into the structure domain and function of NLR family CARD domain containing 5.含CARD结构域的NLR家族成员5的结构域与功能新见解
Cell Commun Signal. 2025 Jan 23;23(1):42. doi: 10.1186/s12964-024-02012-y.
2
A Ménage à trois: NLRC5, immunity, and metabolism.三人行:NLRC5、免疫和代谢。
Front Immunol. 2024 Jul 5;15:1426620. doi: 10.3389/fimmu.2024.1426620. eCollection 2024.